Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aravind Eye Care System is the world’s largest provider of eye care, specializing in high-volume, high-quality, and affordable ophthalmic services, particularly for cataracts, with a mission to eliminate needless blindness[1][2][4]. It operates a dual-hospital model: the Main Hospital for paying patients subsidizes the Free Hospital for those who cannot pay, ensuring equitable access[6]. Aravind performs over 500,000 surgeries per year—more than 60% of the UK’s National Health Service—at a fraction of the cost and with a lower complication rate[6]. The organization’s innovative “assembly line” surgical model and in-house manufacturing of intraocular lenses have driven down costs and increased accessibility[2][6]. Aravind’s outreach includes mobile eye camps and rural vision centers, and it is also a leader in ophthalmic education and training, influencing eye care delivery worldwide[1][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aravind Eye Care System.